Oxford Medical Products is excited to announce successful topline outcomes from the initial randomised controlled trial (RCT) of Sirona, a novel, non-invasive, non-pharmaceutical technology designed to aid weight loss. In a 12-week RCT, Sirona exhibited a good safety profile, was well-tolerated, and demonstrated clear efficacy, with participants in the Sirona group achieving greater weight loss…
No responses yet